ArticleJournal of cellular and molecular medicine2018

High-level expression of ARID1A predicts a favourable outcome in triple-negative breast cancer patients receiving paclitaxel-based chemotherapy.

Yuan-Feng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.